Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | March 18, 2024 |
| Target | Adaptive Phage Therapeutics |
| Sector | Life Science |
| Buyer(s) | BiomX |
| Sellers(s) | Deerfield Management |
| Deal Type | Add-on Acquisition |
FILTER BY
BiomX is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer. BiomX was incorporated in 2015 and is based in Ness Ziona, Israel.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 2 of 2 |
| Type: Add-on Acquisition | 2 of 2 |
| State: Maryland | 1 of 1 |
| Country: United States | 2 of 2 |
| Year: 2024 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-10-28 |
CHAC
New York, New York, United States CHAC is a special purpose acquisition company formed for the purpose of effecting a merger, acquisition, or similar business combination. CHAC was founded in 2017 and is based in New York, New York. |
Buy | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1994 |
| PE ASSETS | 15.0B USD |
| Size | Mega |
| Type | Sector Focused |
Deerfield Management is a hedge fund sponsor focused on public and private company investments in the healthcare sector. Deerfield was established in 1994 and is headquartered in New York, New York.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Add-on Acquisition | 1 of 1 |
| State: Maryland | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2024 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-21 |
Larimar Therapeutics
Bala Cynwyd, Pennsylvania, United States Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar Therapeutics is based in Bala Cynwyd, Pennsylvania. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-23 |
Singular Genomics
San Diego, California, United States Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. Its G4 Sequencing Platform is a versatile benchtop genomic sequencer designed to produce fast and accurate results. The company currently developing the G4X Spatial Sequencer, which will leverage its proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics, and fluorescent H&E in tissue, with spatial context and on the same platform as the G4.. Singular Genomics was formed in 2016 and is based in San Diego, California. |
Buy | - |
